| Financial Year |
March 31 2023 |
| Monetary Funds |
691,285,117.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
50,255,832.97 |
| Accounts Receivable |
924,159,241.25 |
| Advances to Suppliers |
43,637,126.74 |
| Other Receivables |
52,532,191.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
308,743,549.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
89,838,440.98 |
| Other Current Assets |
65,147,322.95 |
| Total Current Assets |
2,272,490,214.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
114,106,625.05 |
| Long-term Equity Investment |
79,917,468.07 |
| Investment Properties |
-- |
| Fixed Assetes |
358,726,591.06 |
| Under-construction Projects |
258,759,551.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,729,646.32 |
| R&D expenses |
-- |
| Goodwill |
367,531,784.31 |
| Long-Term Deferred and Prepaid Expenses |
14,148,126.39 |
| Deferred Income Tax Assets |
65,012,307.66 |
| Other Non-Current Assets |
60,901,839.10 |
| Sub-Total of Non-Current Assets |
1,740,587,437.93 |
| Total Assets |
4,013,077,652.74 |
| Short-Term Loans |
551,923,433.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
179,262,823.03 |
| Accounts Payable |
471,735,842.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,067,523.71 |
| Taxes Payable |
13,079,015.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
458,398,027.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
187,895,451.34 |
| Other Current Liabilities |
29,770,567.55 |
| Sub-Total of Current Liabilities |
2,087,716,072.18 |
| Long-term Loans |
206,398,422.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
51,883,521.38 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,382,312.93 |
| Deferred Income Tax Liabilities |
22,281,282.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
368,951,959.92 |
| Total Liabilities |
2,456,668,032.10 |
| Paid-In Capital(Or Share Stock) |
246,322,260.00 |
| Capital Surplus |
906,598,028.81 |
| Surplus Reserve |
31,075,816.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
166,337,235.75 |
| Minority Stockholder's Interest |
95,809,613.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,460,600,007.56 |
| Owner's Equity（Stockholder's Equity） |
1,556,409,620.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,013,077,652.74 |
